PRRT of neuroendocrine tumors: individualized dosimetry or fixed dose scheme?
Abstract Great efforts have been made in dosimetry for individualizing PRRT. However, many centers do not use dosimetry and its results hardly influence treatment. A reason for that is that reliable thresholds for organs-at-risk, kidneys and bone marrow, and treatment response are lacking. The nucle...